首页 > 最新文献

Heart, Lung and Circulation最新文献

英文 中文
Does Coronary Artery Bypass Grafting Timing Matter? How Early to Operate Diabetic Patients With Acute Myocardial Infarction 冠状动脉旁路移植手术时机重要吗?糖尿病急性心肌梗死患者应尽早手术
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 DOI: 10.1016/j.hlc.2024.08.005
Lijo N. Varghese MSc, Rajesh Katare MBBS, PhD
{"title":"Does Coronary Artery Bypass Grafting Timing Matter? How Early to Operate Diabetic Patients With Acute Myocardial Infarction","authors":"Lijo N. Varghese MSc, Rajesh Katare MBBS, PhD","doi":"10.1016/j.hlc.2024.08.005","DOIUrl":"10.1016/j.hlc.2024.08.005","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"33 9","pages":"Pages 1235-1236"},"PeriodicalIF":2.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142167945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Echoing Concerns: Tackling Rheumatic Heart Disease in Pregnant First Nations Women 回应关切:解决原住民孕妇的风湿性心脏病问题
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 DOI: 10.1016/j.hlc.2024.08.007
R. Kimberley Chan MD , Benedict T. Costello MBBS, FRACP , Elizabeth D. Paratz MBBS, PhD, FRACP
{"title":"Echoing Concerns: Tackling Rheumatic Heart Disease in Pregnant First Nations Women","authors":"R. Kimberley Chan MD , Benedict T. Costello MBBS, FRACP , Elizabeth D. Paratz MBBS, PhD, FRACP","doi":"10.1016/j.hlc.2024.08.007","DOIUrl":"10.1016/j.hlc.2024.08.007","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"33 9","pages":"Pages 1239-1241"},"PeriodicalIF":2.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142167947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protocol Variation in Functional Coronary Angiography Among Patients With Suspected Angina With Non-Obstructive Coronary Arteries: A Nationwide Snapshot of Current Practice Within Australia and New Zealand 疑似冠状动脉非阻塞性心绞痛患者的功能性冠状动脉造影术方案差异:澳大利亚和新西兰全国范围内的现行实践快照。
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 DOI: 10.1016/j.hlc.2024.04.299

Background

Functional coronary angiography (FCA) for endotype characterisation (vasospastic angina [VSA], coronary microvascular disease [CMD], or mixed) is recommended among patients with angina with non-obstructive coronary arteries. Whilst clear diagnostic criteria for VSA and CMD exist, there is no standardised FCA protocol. Variations in testing protocol may limit the widespread uptake of testing, generalisability of results, and expansion of collaborative research. At present, there are no data describing protocol variation across an entire geographic region. Therefore, we aimed to capture current practice variations in the approach to FCA to improve access and standardisation for diagnosis of coronary vasomotor disorders in Australia and New Zealand.

Method

Between July 2022 and July 2023, we conducted a national survey across all centres in Australia and New Zealand with an active FCA program. The survey captured attitudes towards FCA and protocols used for diagnosis of coronary vasomotor disorders at 33 hospitals across Australia and New Zealand.

Results

Survey responses were received from 39 clinicians from 33 centres, with representation from centres within all Australian states and territories and both North and South Islands of New Zealand. A total of 21 centres were identified as having an active FCA program. In general, respondents agreed that comprehensive physiology testing helped inform clinical management. Barriers to program expansion included cost, additional catheter laboratory time, and the absence of an agreed-upon national protocol. Across the clinical sites, there were significant variations in testing protocol, including the technique used (Doppler vs thermodilution), order of testing (hyperaemia resistance indices first vs vasomotor function testing first), rate and dose of acetylcholine administration, routine use of temporary pacing wire, and routine single vs multivessel testing. Overall, testing was performed relatively infrequently, with very little follow-on FCA performed, despite nearly all respondents believing this would be clinically useful.

Conclusions

This survey demonstrates, for the first time, variations in FCA protocol among testing centres across two entire countries. Furthermore, whilst FCA was deemed clinically important, testing was performed relatively infrequently with little or no follow-on testing. Development and adoption of a standardised national FCA protocol may help improve patient access to testing and facilitate further collaborative research within Australia and New Zealand.

背景:建议对冠状动脉无阻塞的心绞痛患者进行功能性冠状动脉造影(FCA)以确定内型特征(血管痉挛性心绞痛 [VSA]、冠状动脉微血管疾病 [CMD] 或混合型)。虽然 VSA 和 CMD 有明确的诊断标准,但目前还没有标准化的 FCA 方案。检测方案的不同可能会限制检测的普及、结果的普遍性以及合作研究的扩展。目前,还没有数据描述整个地理区域的方案差异。因此,我们的目标是掌握当前 FCA 方法的实践差异,以提高澳大利亚和新西兰冠状血管运动障碍诊断的可及性和标准化:方法:2022 年 7 月至 2023 年 7 月期间,我们对澳大利亚和新西兰所有开展 FCA 项目的中心进行了一次全国性调查。调查了解了澳大利亚和新西兰33家医院对FCA的态度以及用于诊断冠状动脉血管运动障碍的方案:调查收到了来自 33 家中心的 39 名临床医生的回复,其中包括澳大利亚各州和领地以及新西兰南北岛的中心代表。共有 21 家中心被确认为拥有积极的 FCA 计划。总体而言,受访者一致认为综合生理学测试有助于为临床管理提供依据。项目扩展的障碍包括成本、额外的导管实验室时间以及缺乏一致认可的国家协议。各临床研究机构的检测方案存在显著差异,包括使用的技术(多普勒与热稀释)、检测顺序(高血流阻力指数优先与血管运动功能检测优先)、乙酰胆碱给药速度和剂量、临时起搏导线的常规使用以及常规单血管检测与多血管检测。总体而言,尽管几乎所有受访者都认为 FCA 对临床有用,但测试的频率相对较低,很少进行后续 FCA:这项调查首次展示了两个国家的检测中心在 FCA 方案上的差异。此外,虽然 FCA 被认为在临床上很重要,但检测的频率相对较低,很少或根本没有后续检测。制定和采用标准化的国家 FCA 方案可能有助于改善患者接受检测的机会,并促进澳大利亚和新西兰国内的进一步合作研究。
{"title":"Protocol Variation in Functional Coronary Angiography Among Patients With Suspected Angina With Non-Obstructive Coronary Arteries: A Nationwide Snapshot of Current Practice Within Australia and New Zealand","authors":"","doi":"10.1016/j.hlc.2024.04.299","DOIUrl":"10.1016/j.hlc.2024.04.299","url":null,"abstract":"<div><h3>Background</h3><p>Functional coronary angiography (FCA) for endotype characterisation (vasospastic angina [VSA], coronary microvascular disease [CMD], or mixed) is recommended among patients with angina with non-obstructive coronary arteries. Whilst clear diagnostic criteria for VSA and CMD exist, there is no standardised FCA protocol. Variations in testing protocol may limit the widespread uptake of testing, generalisability of results, and expansion of collaborative research. At present, there are no data describing protocol variation across an entire geographic region. Therefore, we aimed to capture current practice variations in the approach to FCA to improve access and standardisation for diagnosis of coronary vasomotor disorders in Australia and New Zealand.</p></div><div><h3>Method</h3><p>Between July 2022 and July 2023, we conducted a national survey across all centres in Australia and New Zealand with an active FCA program. The survey captured attitudes towards FCA and protocols used for diagnosis of coronary vasomotor disorders at 33 hospitals across Australia and New Zealand.</p></div><div><h3>Results</h3><p>Survey responses were received from 39 clinicians from 33 centres, with representation from centres within all Australian states and territories and both North and South Islands of New Zealand. A total of 21 centres were identified as having an active FCA program. In general, respondents agreed that comprehensive physiology testing helped inform clinical management. Barriers to program expansion included cost, additional catheter laboratory time, and the absence of an agreed-upon national protocol. Across the clinical sites, there were significant variations in testing protocol, including the technique used (Doppler vs thermodilution), order of testing (hyperaemia resistance indices first vs vasomotor function testing first), rate and dose of acetylcholine administration, routine use of temporary pacing wire, and routine single vs multivessel testing. Overall, testing was performed relatively infrequently, with very little follow-on FCA performed, despite nearly all respondents believing this would be clinically useful.</p></div><div><h3>Conclusions</h3><p>This survey demonstrates, for the first time, variations in FCA protocol among testing centres across two entire countries. Furthermore, whilst FCA was deemed clinically important, testing was performed relatively infrequently with little or no follow-on testing. Development and adoption of a standardised national FCA protocol may help improve patient access to testing and facilitate further collaborative research within Australia and New Zealand.</p></div>","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"33 9","pages":"Pages 1287-1296"},"PeriodicalIF":2.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1443950624005882/pdfft?md5=3efce33be6a22c0bbd43b95d1342dac1&pid=1-s2.0-S1443950624005882-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141476482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Appropriateness of ChatGPT in Answering Heart Failure Related Questions ChatGPT 在回答心力衰竭相关问题时的适用性。
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 DOI: 10.1016/j.hlc.2024.03.005

Background

Heart failure requires complex management, and increased patient knowledge has been shown to improve outcomes. This study assessed the knowledge of Chat Generative Pre-trained Transformer (ChatGPT) and its appropriateness as a supplemental resource of information for patients with heart failure.

Method

A total of 107 frequently asked heart failure-related questions were included in 3 categories: “basic knowledge” (49), “management” (41) and “other” (17). Two responses per question were generated using both GPT-3.5 and GPT-4 (i.e., two responses per question per model). The accuracy and reproducibility of responses were graded by two reviewers, board-certified in cardiology, with differences resolved by a third reviewer, board-certified in cardiology and advanced heart failure. Accuracy was graded using a four-point scale: (1) comprehensive, (2) correct but inadequate, (3) some correct and some incorrect, and (4) completely incorrect.

Results

GPT-4 provided 107/107 (100%) responses with correct information. Further, GPT-4 displayed a greater proportion of comprehensive knowledge for the categories of “basic knowledge” and “management” (89.8% and 82.9%, respectively). For GPT-3, there were two total responses (1.9%) graded as “some correct and incorrect” for GPT-3.5, while no “completely incorrect” responses were produced. With respect to comprehensive knowledge, GPT-3.5 performed best in the “management” category and “other” category (prognosis, procedures, and support) (78.1%, 94.1%). The models also provided highly reproducible responses, with GPT-3.5 scoring above 94% in every category and GPT-4 with 100% for all answers.

Conclusions

GPT-3.5 and GPT-4 answered the majority of heart failure-related questions accurately and reliably. If validated in future studies, ChatGPT may serve as a useful tool in the future by providing accessible health-related information and education to patients living with heart failure. In its current state, ChatGPT necessitates further rigorous testing and validation to ensure patient safety and equity across all patient demographics.

背景:心力衰竭需要复杂的管理,而增加患者知识已被证明可以改善预后。本研究评估了聊天生成预训练转换器(ChatGPT)的知识及其作为心衰患者补充信息资源的适当性:共有 107 个与心力衰竭相关的常见问题被分为 3 类:"基础知识"(49 个)、"管理"(41 个)和 "其他"(17 个)。每个问题使用 GPT-3.5 和 GPT-4 生成两个回答(即每个模型每个问题有两个回答)。回答的准确性和可重复性由两名获得心脏病学专业认证的评审员进行评分,不同意见由第三名获得心脏病学和高级心力衰竭专业认证的评审员解决。准确性采用四级评分法:(1) 全面,(2) 正确但不充分,(3) 部分正确,部分不正确,(4) 完全不正确:结果:GPT-4 提供了 107/107 个(100%)具有正确信息的回答。此外,GPT-4 在 "基础知识 "和 "管理 "类别中显示出更大比例的全面知识(分别为 89.8% 和 82.9%)。就 GPT-3 而言,在 GPT-3.5 中,共有两份答卷(1.9%)被评为 "部分正确,部分不正确",但没有 "完全不正确 "的答卷。在综合知识方面,GPT-3.5 在 "管理 "类别和 "其他 "类别(预后、程序和支持)中表现最佳(78.1%、94.1%)。这些模型还提供了具有高度可重复性的答案,GPT-3.5 在每个类别中的得分都高于 94%,而 GPT-4 在所有答案中的得分均为 100%:结论:GPT-3.5 和 GPT-4 能准确可靠地回答大多数心衰相关问题。如果在未来的研究中得到验证,ChatGPT 将成为一种有用的工具,为心衰患者提供便捷的健康相关信息和教育。就目前的状况而言,ChatGPT 还需要进一步的严格测试和验证,以确保患者的安全和在所有患者人口统计学中的公平性。
{"title":"Appropriateness of ChatGPT in Answering Heart Failure Related Questions","authors":"","doi":"10.1016/j.hlc.2024.03.005","DOIUrl":"10.1016/j.hlc.2024.03.005","url":null,"abstract":"<div><h3>Background</h3><p>Heart failure requires complex management, and increased patient knowledge has been shown to improve outcomes. This study assessed the knowledge of Chat Generative Pre-trained Transformer (ChatGPT) and its appropriateness as a supplemental resource of information for patients with heart failure.</p></div><div><h3>Method</h3><p>A total of 107 frequently asked heart failure-related questions were included in 3 categories: “basic knowledge” (49), “management” (41) and “other” (17). Two responses per question were generated using both GPT-3.5 and GPT-4 (i.e., two responses per question per model). The accuracy and reproducibility of responses were graded by two reviewers, board-certified in cardiology, with differences resolved by a third reviewer, board-certified in cardiology and advanced heart failure. Accuracy was graded using a four-point scale: (1) comprehensive, (2) correct but inadequate, (3) some correct and some incorrect, and (4) completely incorrect.</p></div><div><h3>Results</h3><p>GPT-4 provided 107/107 (100%) responses with correct information. Further, GPT-4 displayed a greater proportion of comprehensive knowledge for the categories of “basic knowledge” and “management” (89.8% and 82.9%, respectively). For GPT-3, there were two total responses (1.9%) graded as “some correct and incorrect” for GPT-3.5, while no “completely incorrect” responses were produced. With respect to comprehensive knowledge, GPT-3.5 performed best in the “management” category and “other” category (prognosis, procedures, and support) (78.1%, 94.1%). The models also provided highly reproducible responses, with GPT-3.5 scoring above 94% in every category and GPT-4 with 100% for all answers.</p></div><div><h3>Conclusions</h3><p>GPT-3.5 and GPT-4 answered the majority of heart failure-related questions accurately and reliably. If validated in future studies, ChatGPT may serve as a useful tool in the future by providing accessible health-related information and education to patients living with heart failure. In its current state, ChatGPT necessitates further rigorous testing and validation to ensure patient safety and equity across all patient demographics.</p></div>","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"33 9","pages":"Pages 1314-1318"},"PeriodicalIF":2.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1443950624001653/pdfft?md5=19c34317ccf8cf7b45fd251e734d1e0c&pid=1-s2.0-S1443950624001653-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141183432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Admission Left-Arm Systolic Blood Pressure and In-Hospital Mortality After Acute Type A Aortic Dissection Repair 入院时左臂收缩压与急性 A 型主动脉夹层修复后的院内死亡率
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 DOI: 10.1016/j.hlc.2024.03.017

Aim

Admission systolic blood pressure is a significant predictor of in-hospital mortality in patients with acute type A aortic dissection (ATAAD). While previous studies have focussed on recording the highest blood pressure value from both arms, this study aimed to evaluate the associations between blood pressure in bilateral arms and in-hospital mortality.

Methods

Data were analysed from 262 patients with ATAAD treated at a single centre. The relationship between bilateral arm blood pressure upon admission and in-hospital mortality was assessed in a logistic regression model. To comprehensively evaluate potential non-linear relationships, the association between admission bilateral systolic blood pressure (SBP) and the risk of in-hospital mortality was analysed using restricted cubic splines on a continuous scale.

Results

Mean age was 53.6±12.5 years and 194 (74.0%) were male. Baseline and operative data showed that ages, body mass index, smoking, left-arm SBP, left-arm diastolic blood pressure (DBP), right-arm SBP, right-arm DBP, syncope, cerebral/cardiac ischaemia, retrograde brain perfusion, Bentall procedure, coronary artery bypass grafting, and aortic valve replacement significantly differed among the left-arm SBP tertiles. In-hospital mortality was 17.6% (46 of 262). Restricted cubic splines demonstrated that the relationship between presenting left-arm SBP and in-hospital mortality followed a U-shaped curve, whereas non-linearity was not detected in the right arm.

Conclusion

This study found a U-shaped association between admission left-arm SBP and in-hospital mortality in ATAAD surgery patients, whereas a non-linearity relationship was not detected for right-arm SBP. Low left-arm SBP independently correlated with increased in-hospital mortality, underscoring the significance of bilateral blood pressure differences in ATAAD prognosis.

目的:入院收缩压是急性A型主动脉夹层(ATAAD)患者院内死亡率的重要预测因素。以往的研究侧重于记录双臂的最高血压值,而本研究旨在评估双臂血压与院内死亡率之间的关联:方法:分析了在一个中心接受治疗的 262 名 ATAAD 患者的数据。在逻辑回归模型中评估了入院时双臂血压与院内死亡率之间的关系。为了全面评估潜在的非线性关系,在连续尺度上使用限制性立方样条分析了入院时双侧收缩压(SBP)与院内死亡风险之间的关系:平均年龄(53.6±12.5)岁,男性 194 人(74.0%)。基线和手术数据显示,年龄、体重指数、吸烟、左臂 SBP、左臂舒张压 (DBP)、右臂 SBP、右臂 DBP、晕厥、脑/心缺血、逆行脑灌注、Bentall 手术、冠状动脉旁路移植术和主动脉瓣置换术在左臂 SBP 三元组之间存在显著差异。院内死亡率为 17.6%(262 例中有 46 例)。限制性三次样条显示,左臂SBP与住院死亡率之间的关系呈U形曲线,而右臂则未发现非线性关系:本研究发现,ATAAD 手术患者入院时左臂血压与院内死亡率呈 U 型关系,而右臂血压未发现非线性关系。左臂SBP低与院内死亡率增加呈独立相关性,这突出表明了双侧血压差异在ATAAD预后中的重要性。
{"title":"Admission Left-Arm Systolic Blood Pressure and In-Hospital Mortality After Acute Type A Aortic Dissection Repair","authors":"","doi":"10.1016/j.hlc.2024.03.017","DOIUrl":"10.1016/j.hlc.2024.03.017","url":null,"abstract":"<div><h3>Aim</h3><p>Admission systolic blood pressure is a significant predictor of in-hospital mortality in patients with acute type A aortic dissection (ATAAD). While previous studies have focussed on recording the highest blood pressure value from both arms, this study aimed to evaluate the associations between blood pressure in bilateral arms and in-hospital mortality.</p></div><div><h3>Methods</h3><p>Data were analysed from 262 patients with ATAAD treated at a single centre. The relationship between bilateral arm blood pressure upon admission and in-hospital mortality was assessed in a logistic regression model. To comprehensively evaluate potential non-linear relationships, the association between admission bilateral systolic blood pressure (SBP) and the risk of in-hospital mortality was analysed using restricted cubic splines on a continuous scale.</p></div><div><h3>Results</h3><p>Mean age was 53.6±12.5 years and 194 (74.0%) were male. Baseline and operative data showed that ages, body mass index, smoking, left-arm SBP, left-arm diastolic blood pressure (DBP), right-arm SBP, right-arm DBP, syncope, cerebral/cardiac ischaemia, retrograde brain perfusion, Bentall procedure, coronary artery bypass grafting, and aortic valve replacement significantly differed among the left-arm SBP tertiles. In-hospital mortality was 17.6% (46 of 262). Restricted cubic splines demonstrated that the relationship between presenting left-arm SBP and in-hospital mortality followed a U-shaped curve, whereas non-linearity was not detected in the right arm.</p></div><div><h3>Conclusion</h3><p>This study found a U-shaped association between admission left-arm SBP and in-hospital mortality in ATAAD surgery patients, whereas a non-linearity relationship was not detected for right-arm SBP. Low left-arm SBP independently correlated with increased in-hospital mortality, underscoring the significance of bilateral blood pressure differences in ATAAD prognosis.</p></div>","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"33 9","pages":"Pages 1357-1364"},"PeriodicalIF":2.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1443950624004815/pdfft?md5=07ac0434d80d1056bfc8a4d1aaa1d02a&pid=1-s2.0-S1443950624004815-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141456342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disparities in Cardiac Magnetic Resonance Imaging Service Provision Between Australia and the United Kingdom 澳大利亚和英国在心脏磁共振成像服务提供方面的差异
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 DOI: 10.1016/j.hlc.2024.03.018
James Nadel MBBS, FRACP, PhD
{"title":"Disparities in Cardiac Magnetic Resonance Imaging Service Provision Between Australia and the United Kingdom","authors":"James Nadel MBBS, FRACP, PhD","doi":"10.1016/j.hlc.2024.03.018","DOIUrl":"10.1016/j.hlc.2024.03.018","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"33 9","pages":"Pages e47-e48"},"PeriodicalIF":2.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142167862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of In-Hospital Mortality in Type A Acute Aortic Syndrome: Data From the RENADA-RO Registry A 型急性主动脉综合征院内死亡率的预测因素:来自 RENADA-RO 登记处的数据。
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 DOI: 10.1016/j.hlc.2024.02.016

Background

This study aimed to analyse the baseline characteristics of patients admitted with acute type A aortic syndrome (ATAAS) and to identify the potential predictors of in-hospital mortality in surgically managed patients.

Methods

Data regarding demographics, clinical presentation, laboratory work-up, and management of 501 patients with ATAAS enrolled in the National Registry of Aortic Dissections—Romania registry from January 2011 to December 2022 were evaluated. The primary endpoint was in-hospital all-cause mortality. Multivariate logistic regression was conducted to identify independent predictors of mortality in patients with acute Type A aortic dissection (ATAAD) who underwent surgery.

Results

The mean age was 60±11 years and 65% were male. Computed tomography was the first-line diagnostic tool (79%), followed by transoesophageal echocardiography (21%). Cardiac surgery was performed in 88% of the patients. The overall mortality in the entire cohort was 37.9%, while surgically managed ATAAD patients had an in-hospital mortality rate of 29%. In multivariate logistic regression, creatinine value (OR 6.76), ST depression on ECG (OR 6.3), preoperative malperfusion (OR 5.77), cardiogenic shock (OR 5.77), abdominal pain (OR 4.27), age ≥70 years (OR 3.76), and syncope (OR 3.43) were independently associated with in-hospital mortality in surgically managed ATAAD patients.

Conclusions

Risk stratification based on the variables collected at admission may help to identify ATAAS patients with high risk of death following cardiac surgery.

背景:本研究旨在分析急性A型主动脉综合征(ATAAS)入院患者的基线特征,并确定手术治疗患者院内死亡率的潜在预测因素:本研究旨在分析急性A型主动脉综合征(ATAAS)入院患者的基线特征,并确定手术治疗患者院内死亡率的潜在预测因素:方法: 对2011年1月至2022年12月期间在罗马尼亚国家主动脉夹层登记处登记的501名A型主动脉综合征患者的人口统计学、临床表现、实验室检查和管理数据进行了评估。主要终点是院内全因死亡率。对接受手术的急性A型主动脉夹层(ATAAD)患者进行了多变量逻辑回归,以确定死亡率的独立预测因素:平均年龄为(60±11)岁,65%为男性。计算机断层扫描是一线诊断工具(79%),其次是经食道超声心动图(21%)。88%的患者接受了心脏手术。整个队列的总死亡率为 37.9%,而接受手术治疗的 ATAAD 患者的院内死亡率为 29%。在多变量逻辑回归中,肌酐值(OR 6.76)、心电图ST压低(OR 6.3)、术前灌注不良(OR 5.77)、心源性休克(OR 5.77)、腹痛(OR 4.27)、年龄≥70岁(OR 3.76)和晕厥(OR 3.43)与手术治疗的ATAAD患者的院内死亡率独立相关:根据入院时收集的变量进行风险分层有助于识别心脏手术后死亡风险较高的 ATAAS 患者。
{"title":"Predictors of In-Hospital Mortality in Type A Acute Aortic Syndrome: Data From the RENADA-RO Registry","authors":"","doi":"10.1016/j.hlc.2024.02.016","DOIUrl":"10.1016/j.hlc.2024.02.016","url":null,"abstract":"<div><h3>Background</h3><p>This study aimed to analyse the baseline characteristics of patients admitted with acute type A aortic syndrome (ATAAS) and to identify the potential predictors of in-hospital mortality in surgically managed patients.</p></div><div><h3>Methods</h3><p>Data regarding demographics, clinical presentation, laboratory work-up, and management of 501 patients with ATAAS enrolled in the National Registry of Aortic Dissections—Romania registry from January 2011 to December 2022 were evaluated. The primary endpoint was in-hospital all-cause mortality. Multivariate logistic regression was conducted to identify independent predictors of mortality in patients with acute Type A aortic dissection (ATAAD) who underwent surgery.</p></div><div><h3>Results</h3><p><span>The mean age was 60±11 years and 65% were male. Computed tomography<span> was the first-line diagnostic tool (79%), followed by transoesophageal echocardiography (21%). Cardiac surgery was performed in 88% of the patients. The overall mortality in the entire cohort was 37.9%, while surgically managed ATAAD patients had an in-hospital mortality rate of 29%. In multivariate logistic regression, creatinine value (OR 6.76), ST depression on ECG (OR 6.3), preoperative malperfusion (OR 5.77), </span></span>cardiogenic shock (OR 5.77), abdominal pain (OR 4.27), age ≥70 years (OR 3.76), and syncope (OR 3.43) were independently associated with in-hospital mortality in surgically managed ATAAD patients.</p></div><div><h3>Conclusions</h3><p>Risk stratification based on the variables collected at admission may help to identify ATAAS patients with high risk of death following cardiac surgery.</p></div>","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"33 9","pages":"Pages 1348-1356"},"PeriodicalIF":2.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141491670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative Nonselective Chest Computed Tomography Prior to Primary Cardiac Surgery Results in Meaningful Change to Surgical Management: Systematic Review and Pooled Prevalence Meta-Analysis 原发性心脏手术前的术前非选择性胸部计算机断层扫描导致手术管理的重大改变:系统综述和汇总患病率元分析》。
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 DOI: 10.1016/j.hlc.2024.04.302

Background

Routine screening chest computed tomography (CT) prior to primary cardiac surgery is advocated by some surgeons due to the purported benefits of identifying significant aortic calcification that impacts ongoing management, such as performing anaortic off-pump surgery or adjusting cannulation strategy. Additionally, axial imaging can identify incidental findings that may require concomitant or staged procedures such as ascending aortic dilatation or pulmonary lesions. The objective of this study was to quantify the impact that nonselective chest CT prior to primary cardiac surgery had on subsequent management.

Method

A systematic review and pooled prevalence meta-analyses were performed in accordance with Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Included studies performed non-selective chest CT prior to primary cardiac surgery.

Results

A total of eight studies, including 2,250 patients were included. The rate of mortality and stroke was low (1% and 2%, respectively). Calcification of the ascending aorta was identified in 15% of patients (95% confidence interval [CI] 5.0–26.0). A significant change to the surgical plan such as cannulation strategy, off-pump surgery, cancellation, or an additional procedure was required in 7% (95% CI 2.0–12.0). Clinically relevant incidental findings requiring in-patient management or follow-up were identified in 10% (95% CI 6.0–14.0).

Conclusions

Nonselective CT chest prior to primary cardiac surgery identifies clinically relevant findings that result in a modification of the surgical plan in a significant population of patients to address the risk of stroke associated with aortic calcification as well as the identification of important incidental findings such as pulmonary lesions.

背景:一些外科医生主张在初级心脏手术前常规筛查胸部计算机断层扫描 (CT),因为据说这样做的好处是可以发现明显的主动脉钙化,从而影响正在进行的管理,如进行主动脉离泵手术或调整插管策略。此外,轴向成像还能发现可能需要同时或分期手术的偶然发现,如升主动脉扩张或肺部病变。本研究的目的是量化初级心脏手术前非选择性胸部 CT 对后续管理的影响:方法:根据《系统综述和荟萃分析首选报告项目》指南,进行了系统综述和集合流行率荟萃分析。纳入的研究在心脏外科手术前进行了非选择性胸部 CT:共纳入 8 项研究,包括 2250 名患者。死亡率和中风率较低(分别为 1% 和 2%)。15%的患者发现升主动脉钙化(95% 置信区间 [CI] 5.0-26.0)。有 7% 的患者(95% 置信区间 [CI]:2.0-12.0)需要对手术计划进行重大调整,如插管策略、非泵手术、取消手术或增加额外手术。10%(95% CI 6.0-14.0)的患者发现了需要住院治疗或随访的临床相关附带结果:结论:原发性心脏手术前的胸部非选择性 CT 可确定临床相关的发现,从而修改相当一部分患者的手术计划,以应对与主动脉钙化相关的中风风险,并确定重要的偶然发现,如肺部病变。
{"title":"Preoperative Nonselective Chest Computed Tomography Prior to Primary Cardiac Surgery Results in Meaningful Change to Surgical Management: Systematic Review and Pooled Prevalence Meta-Analysis","authors":"","doi":"10.1016/j.hlc.2024.04.302","DOIUrl":"10.1016/j.hlc.2024.04.302","url":null,"abstract":"<div><h3>Background</h3><p>Routine screening chest computed tomography<span> (CT) prior to primary cardiac surgery is advocated by some surgeons due to the purported benefits of identifying significant aortic calcification that impacts ongoing management, such as performing anaortic off-pump surgery or adjusting cannulation<span> strategy. Additionally, axial imaging can identify incidental findings<span> that may require concomitant or staged procedures such as ascending aortic dilatation or pulmonary lesions. The objective of this study was to quantify the impact that nonselective chest CT prior to primary cardiac surgery had on subsequent management.</span></span></span></p></div><div><h3>Method</h3><p>A systematic review and pooled prevalence meta-analyses were performed in accordance with Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Included studies performed non-selective chest CT prior to primary cardiac surgery.</p></div><div><h3>Results</h3><p>A total of eight studies, including 2,250 patients were included. The rate of mortality and stroke was low (1% and 2%, respectively). Calcification of the ascending aorta was identified in 15% of patients (95% confidence interval [CI] 5.0–26.0). A significant change to the surgical plan such as cannulation strategy, off-pump surgery, cancellation, or an additional procedure was required in 7% (95% CI 2.0–12.0). Clinically relevant incidental findings requiring in-patient management or follow-up were identified in 10% (95% CI 6.0–14.0).</p></div><div><h3>Conclusions</h3><p>Nonselective CT chest prior to primary cardiac surgery identifies clinically relevant findings that result in a modification of the surgical plan in a significant population of patients to address the risk of stroke associated with aortic calcification as well as the identification of important incidental findings such as pulmonary lesions.</p></div>","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"33 9","pages":"Pages 1250-1258"},"PeriodicalIF":2.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141563301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heart Foundation launches new MyHeart MyLife patient support program 心脏基金会推出新的 "我的心脏我的生活 "患者支持计划
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 DOI: 10.1016/j.hlc.2024.08.004
{"title":"Heart Foundation launches new MyHeart MyLife patient support program","authors":"","doi":"10.1016/j.hlc.2024.08.004","DOIUrl":"10.1016/j.hlc.2024.08.004","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"33 9","pages":"Page 1379"},"PeriodicalIF":2.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1443950624017761/pdfft?md5=34b3e1077b334c9854af1ce071a7596c&pid=1-s2.0-S1443950624017761-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142167864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-Procedure Monocyte Count Levels Predict Major Adverse Cardiovascular Events (MACE) Following Transcatheter Aortic Valve Implantation (TAVI) for Aortic Stenosis 经导管主动脉瓣膜植入术 (TAVI) 治疗主动脉瓣狭窄术后单核细胞计数水平可预测主要不良心血管事件 (MACE)。
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 DOI: 10.1016/j.hlc.2024.03.013

Background

Aortic stenosis has recently been characterised as having an inflammatory aetiology, beyond the traditional degenerative model. Recruitment of monocytes has been associated with inflammation contributing to progression of calcific aortic-valve disease. Prior research has demonstrated that pre-procedure inflammatory biomarkers do not consistently discriminate poorer outcomes in those with aortic stenosis. It remains, however, unclear if postprocedure inflammatory biomarkers, which are influenced by intraprocedural pro-inflammatory insults, can predict major adverse cardiovascular events (MACE) post transcatheter aortic valve implantation (TAVI).

Method

All patients with postprocedure monocyte levels undergoing transcatheter aortic valve implantation at The Alfred Hospital, Melbourne, Australia (2008–2019) were included. The highest monocyte count from postprocedure days 1 to 3 was used. Patients were divided into “high” or “low” postprocedure monocyte count groups using the Youden Index. The incidence of 30-day MACE a composite of stroke, acute myocardial infarction, and death) was then compared.

Results

In total, 472 patients were included (54% men, median age 84 years). Fourteen (14) patients (3%) suffered a 30-day MACE. Those with high postprocedure monocyte count were more likely to: be hypertensive (p=0.049); have a higher Society of Thoracic Surgeons risk score (p=0.032); and, undergo non-transfemoral access (p=0.018). A high (≥0.975) postprocedure monocyte count was significantly associated with 30-day MACE (odds ratio [OR] 1.16 for each 0.1 increase in monocyte, p=0.025). This association remained present on multivariable analysis adjusted for age, sex, Society of Thoracic Surgeons risk score, and self-expanding valve prosthesis type (OR 1.17, p=0.028).

Conclusions

The association between postprocedure monocytosis and 30-day MACE suggests that minimising peri-procedural inflammatory insults may improve outcomes. This inexpensive and readily available biomarker may also aid in tailored risk stratification for patients.

背景:最近,主动脉瓣狭窄被认为是一种炎症性病因,而非传统的退行性病因。单核细胞的募集与炎症有关,而炎症会导致钙化主动脉瓣疾病的进展。先前的研究表明,手术前的炎症生物标志物并不能持续区分主动脉瓣狭窄患者的不良预后。但经导管主动脉瓣植入术(TAVI)术后炎症生物标志物是否能预测经导管主动脉瓣植入术(TAVI)术后的主要不良心血管事件(MACE),目前仍不清楚:方法:纳入澳大利亚墨尔本阿尔弗雷德医院接受经导管主动脉瓣植入术(2008-2019年)的所有术后单核细胞水平的患者。采用术后第1至3天的最高单核细胞计数。采用尤登指数将患者分为术后单核细胞计数 "高 "组和 "低 "组。然后比较了 30 天 MACE(中风、急性心肌梗死和死亡的综合)的发生率:共纳入 472 名患者(54% 为男性,中位年龄为 84 岁)。14名患者(3%)发生了30天的MACE。术后单核细胞计数高的患者更有可能是:高血压患者(P=0.049);胸外科医师协会风险评分较高的患者(P=0.032);以及接受非经股入路手术的患者(P=0.018)。术后单核细胞计数高(≥0.975)与 30 天 MACE 显著相关(单核细胞每增加 0.1,几率比 [OR] 为 1.16,p=0.025)。在对年龄、性别、胸外科医师协会风险评分和自扩张瓣膜类型进行调整后进行多变量分析,这一关联仍然存在(OR 1.17,P=0.028):手术后单核细胞增多与 30 天 MACE 之间的关联表明,尽量减少手术周围的炎症损伤可改善预后。这种价廉易得的生物标志物还有助于对患者进行有针对性的风险分层。
{"title":"Post-Procedure Monocyte Count Levels Predict Major Adverse Cardiovascular Events (MACE) Following Transcatheter Aortic Valve Implantation (TAVI) for Aortic Stenosis","authors":"","doi":"10.1016/j.hlc.2024.03.013","DOIUrl":"10.1016/j.hlc.2024.03.013","url":null,"abstract":"<div><h3>Background</h3><p><span><span>Aortic stenosis has recently been characterised as having an inflammatory aetiology, beyond the traditional degenerative model. Recruitment of </span>monocytes has been associated with inflammation contributing to progression of calcific aortic-valve disease. Prior research has demonstrated that pre-procedure inflammatory biomarkers do not consistently discriminate poorer outcomes in those with aortic stenosis. It remains, however, unclear if postprocedure inflammatory biomarkers, which are influenced by intraprocedural pro-inflammatory insults, can predict major adverse cardiovascular events (MACE) post </span>transcatheter aortic valve implantation (TAVI).</p></div><div><h3>Method</h3><p>All patients with postprocedure monocyte levels undergoing transcatheter aortic valve implantation at The Alfred Hospital, Melbourne, Australia (2008–2019) were included. The highest monocyte count from postprocedure days 1 to 3 was used. Patients were divided into “high” or “low” postprocedure monocyte count groups using the Youden Index<span>. The incidence of 30-day MACE a composite of stroke, acute myocardial infarction, and death) was then compared.</span></p></div><div><h3>Results</h3><p><span>In total, 472 patients were included (54% men, median age 84 years). Fourteen (14) patients (3%) suffered a 30-day MACE. Those with high postprocedure monocyte count were more likely to: be hypertensive (p=0.049); have a higher Society of Thoracic Surgeons risk score (p=0.032); and, undergo non-transfemoral access (p=0.018). A high (≥0.975) postprocedure monocyte count was significantly associated with 30-day MACE (odds ratio [OR] 1.16 for each 0.1 increase in monocyte, p=0.025). This association remained present on multivariable analysis adjusted for age, sex, Society of Thoracic Surgeons risk score, and self-expanding </span>valve prosthesis type (OR 1.17, p=0.028).</p></div><div><h3>Conclusions</h3><p><span>The association between postprocedure monocytosis and 30-day MACE suggests that minimising peri-procedural inflammatory insults may improve outcomes. This inexpensive and readily available biomarker may also aid in tailored </span>risk stratification for patients.</p></div>","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"33 9","pages":"Pages 1340-1347"},"PeriodicalIF":2.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141283559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Heart, Lung and Circulation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1